Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$4.57
+12.16%
Mkt Cap $426.90M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
Implied Upside
+141.0%
Consensus $11.00 vs current $4.57
NASDAQ·Healthcare·Biotechnology
$4.57
+12.16%
Mkt Cap $426.90M
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
+141.0%
Consensus $11.00 vs current $4.57